Zobrazeno 1 - 10
of 14
pro vyhledávání: '"M Christian Tjiam"'
Autor:
Laila N Abudulai, Sonia Fernandez, Karli Corscadden, Sally A Burrows, Michael Hunter, M Christian Tjiam, Lea-Ann S Kirkham, Jeffrey J Post, Martyn A French
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0176641 (2017)
Dysfunction of T follicular-helper (TFH) cells is a possible cause of impaired germinal centre (GC) and IgG antibody responses in individuals with human immunodeficiency virus-1 (HIV-1) infection and might contribute to decreased magnitude and isotyp
Externí odkaz:
https://doaj.org/article/a91e74ee77684e81b9f7fec1a94d0cb3
Autor:
Arya vanAlin, Melissa K. Corbett, Homayoun Fathollahzadeh, M. Christian Tjiam, William D. A. Rickard, Xiao Sun, Andrew Putnis, Jacques Eksteen, Anna H. Kaksonen, Elizabeth Watkin
Publikováno v:
Microbial Biotechnology, Vol 16, Iss 9, Pp 1790-1802 (2023)
Abstract Microbial attachment and biofilm formation is a ubiquitous behaviour of microorganisms and is the most crucial prerequisite of contact bioleaching. Monazite and xenotime are two commercially exploitable minerals containing rare earth element
Externí odkaz:
https://doaj.org/article/1b0eadcc54e84e29a6ac6953b6540e03
Autor:
Arya Van Alin, Melissa K. Corbett, Homayoun Fathollahzadeh, M. Christian Tjiam, Andrew Putnis, Jacques Eksteen, Anna H. Kaksonen, Elizabeth Watkin
Publikováno v:
Microorganisms, Vol 11, Iss 5, p 1331 (2023)
The adsorption behaviour of micro-organisms during the initial attachment stage of biofilm formation affects subsequent stages. The available area for attachment and the chemophysical properties of a surface affect microbial attachment performance. T
Externí odkaz:
https://doaj.org/article/1a1cb94c6fb14f14b070605eea648a43
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The diversity of B cell subsets and their contribution to vaccine-induced immunity in humans are not well elucidated but hold important implications for rational vaccine design. Prior studies demonstrate that B cell subsets distinguished by immunoglo
Externí odkaz:
https://doaj.org/article/b5ac521913de4c2e8b2bc87c18b7f6f8
Autor:
Rodrigo Carlessi, Elena Denisenko, Ebru Boslem, Julia Köhn-Gaone, Nathan Main, N. Dianah B. Abu Bakar, Gayatri D. Shirolkar, Matthew Jones, Aaron B. Beasley, Daniel Poppe, Benjamin J. Dwyer, Connie Jackaman, M. Christian Tjiam, Ryan Lister, Michael Karin, Jonathan A. Fallowfield, Timothy J. Kendall, Stuart J. Forbes, Elin S. Gray, John K. Olynyk, George Yeoh, Alistair R.R. Forrest, Grant A. Ramm, Mark A. Febbraio, Janina E.E. Tirnitz-Parker
Publikováno v:
Carlessi, R, Denisenko, E, Boslem, E, Köhn-Gaone, J, Main, N, Abu bakar, N D B, Shirolkar, G D, Jones, M, Beasley, A B, Poppe, D, Dwyer, B J, Jackaman, C, Tjiam, M C, Lister, R, Karin, M, Fallowfield, J A, Kendall, T J, Forbes, S J, Gray, E S, Olynyk, J K, Yeoh, G, Forrest, A R R, Ramm, G A, Febbraio, M A & Tirnitz-Parker, J E E 2023, ' Single-nucleus RNA sequencing of pre-malignant liver reveals disease-associated hepatocyte state with HCC prognostic potential ', Cell Genomics, pp. 100301 . https://doi.org/10.1016/j.xgen.2023.100301
Current approaches to stage chronic liver diseases have limited utility to predict liver cancer risk. Here, we employed single nucleus RNA sequencing (snRNA-seq) to characterize the cellular microenvironment of healthy and pre-malignant livers using
Autor:
Rodrigo Carlessi, Elena Denisenko, Ebru Boslem, Julia Koehn-Gaone, Nathan Main, N. Dianah B. Abu Bakar, Gayatri D. Shirolkar, Matthew Jones, Daniel Poppe, Benjamin J. Dwyer, Connie Jackaman, M. Christian Tjiam, Ryan Lister, Michael Karin, Jonathan A. Fallowfield, Timothy J. Kendall, Stuart J. Forbes, John K. Olynyk, George Yeoh, Alistair R. R. Forrest, Grant A. Ramm, Mark A. Febbraio, Janina E. E. Tirnitz-Parker
SUMMARYCurrent approaches to stage chronic liver diseases have limited utility to directly predict liver cancer risk. Here, we employed single nucleus RNA sequencing (snRNA-seq) to characterize the cellular microenvironment of healthy and chronically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f6343e879a53fd2c88b13154acb2379
https://doi.org/10.1101/2022.03.25.485695
https://doi.org/10.1101/2022.03.25.485695
Autor:
M. Christian Tjiam, Jesse D. Armitage, Sonia Fernandez, Martyn A. French, James P. A. Taylor, Dino B.A. Tan, Lucy Sariputra, Anthony D. Kelleher, Silvia Lee
Publikováno v:
AIDS. 30:2757-2765
We have previously demonstrated that HIV-1 p24-specific plasmacytoid dendritic cell-reactive opsonophagocytic antibody (PROAb) responses associate with control of chronic HIV infection. Here, we examined whether HIV-1 p24-specific PROAbs associate wi
Autor:
Lucy Sariputra, Silvia Lee, Sonia Fernandez, Sally Burrows, James P. A. Taylor, M. Christian Tjiam, Martyn A. French, Dino B.A. Tan, Mazmah A. Morshidi, Jeffrey N. Martin, Steven G. Deeks
Publikováno v:
The Journal of Immunology. 194:5320-5328
Identifying the mechanisms of natural control of HIV-1 infection could lead to novel approaches to prevent or cure HIV infection. Several studies have associated natural control of HIV-1 infection with IgG antibodies against HIV-1 Gag proteins (e.g.
Autor:
Martyn A. French, Jeffrey N. Martin, Sonia Fernandez, Dino B.A. Tan, Lucy Sariputra, Steven G. Deeks, Silvia Lee, M. Christian Tjiam, Mazmah A. Morshidi
To expand upon our previous observation that HIV-1 Gag-specific IgG antibodies were highest in HIV controllers not carrying HLA-B*57:01, we analysed these antibodies in a larger cohort of viremic controllers (VCs) or elite controllers (ECs) consideri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8846c548fd6c450463417e82cb7fc6dd
https://europepmc.org/articles/PMC5634911/
https://europepmc.org/articles/PMC5634911/
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 8 (2017)
Frontiers in Immunology, Vol 8 (2017)
Contemporary antiretroviral therapy (ART) is effective and tolerable for long periods of time but cannot eradicate human immunodeficiency virus type 1 (HIV-1) infection by either elimination of viral reservoirs or enhancement of HIV-1-specific immune